|

PAS-004 Capsule Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Pasithea Therapeutics Corp.1

Indications

  • Neurofibromatosis Type 1 (NF1)1
  • Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)1
  • Neurofibroma, Plexiform1
  • NF1 Mutation1
  • Cancer1

Birmingham, Alabama1 trial

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.